دورية أكاديمية

P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results.

التفاصيل البيبلوغرافية
العنوان: P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results.
المؤلفون: Ghobrial, Irene, Rodríguez-Otero, Paula, Youngil Koh, Martínez-López, Joaquín, Parmar, Gurdeep, Prince, Miles, Hang Quach, de la Rubia, Javier, Hermansen, Emil, Hungria, Vania, Besisik, Sevgi Kalayoglu, Jin Seok Kim, Leleu, Xavier, Peceliunas, Valdas, Schjesvold, Fredrik, Dubin, Franck, Devisme, Christine, Lepine, Lucie, Macé, Sandrine, Oprea, Codina
المصدر: Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 2, Vol. 21, pS109-S110, 2p
قاعدة البيانات: Complementary Index
الوصف
تدمد:21522650
DOI:10.1016/S2152-2650(21)02264-3